Pursuing claims-based data on what happens to patients taking their drugs, pharma companies have been striking pacts with payers and PBMs. Now, a heavyweight in the research field, IMS Health, has ...
IMS Health’s IPO raised more than $1.3 billion Friday by selling 65 million shares for $20 apiece. Shares quickly rose to $23 during Friday’s trading. Like Castlight Health, whose $3 billion public ...
IMS Health filed for an initial public offering last week, which may raise as much as $1 billion for the healthcare data and consulting firm. IMS Health was acquired in 2010 by private equity firms ...
NEW YORK, April 18 (Reuters) - IMS Health , which provides market data on pharmaceuticals sales, on Wednesday reported first-quarter profit fell 27 percent from a year ago, when it had tax benefits, ...
VNU, owner of the market research firm A.C. Nielsen, is close to a deal to buy data provider IMS Health for $6.3 billion in cash and stock, the Wall Street Journal reported, citing sources it didn’t ...
IQVIA Exceeds Expectations With Robust Q3 Results; Raising FVE to $276 on Improved Near-Term Outlook
The merger with IMS Health provided access to an unparalleled database of patient data, which should strengthen its clinical trial offerings. The ongoing shift to outsourced R&D should provide the CRO ...
NEW YORK (Reuters) - The global prescription drug market grew by 6.4 percent in 2007 to an estimated $712 billion, according to data compiled by IMS Health . While the United States remained the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback